APC c.304T>C ;(p.S102P)

Variant ID: 5-112102969-T-C

NM_000038.5(APC):c.304T>C;(p.S102P)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine
Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W
Publication Date: 2022-09-19

Variant appearance in text: APC: 304T>C; S102P
PubMed Link: 36123678
Variant Present in the following documents:
  • 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.

Oncotarget
Ashktorab, Hassan H; Mokarram, Pooneh P; Azimi, Hamed H; Olumi, Hasti H; Varma, Sudhir S; Nickerson, Michael L ML; Brim, Hassan H
Publication Date: 2017-01-31

Variant appearance in text: APC: S102P
PubMed Link: 28002797
Variant Present in the following documents:
  • oncotarget-08-7852-s002.xlsx, sheet 17
View BVdb publication page



Overcoming a species-specificity barrier in development of an inhibitory antibody targeting a modulator of tumor stroma.

Protein Engineering, Design & Selection : Peds
Grossman, Iris I; Ilani, Tal T; Fleishman, Sarel Jacob SJ; Fass, Deborah D
Publication Date: 2016-04

Variant appearance in text: APC: S102P
PubMed Link: 26819240
Variant Present in the following documents:
  • Main text
  • gzv067.pdf
View BVdb publication page